期刊文献+

基于Web of Science的药物基因组学文献计量分析 被引量:6

Bibliometric analysis of pharmacogenomic literature based on Web of Science
原文传递
导出
摘要 目的:确定药物基因组学文献分布特点和主要研究方向,为今后研究药物基因组学相关课题提供依据。方法:运用文献计量学的方法对Web of Science数据库收录的药物基因组学相关文献进行分析。结果:统计范围内共有8 037篇文献,近年来文献数量增长迅速,确定了以《Pharmacogenomics》为主的10种药物基因组学核心期刊,以Mcleod HL为首的10位多产作者及被引频次居前10位的文献。近几年来中国在药物基因组学研究取得了巨大的进步,但是仍落后于世界先进国家。结论:药物基因组学研究领域越来越受重视,相应的科研产出量将持续增加,我国研究者应该加强国际合作与研究水平。 Objective:To investigate the distribution characteristics and research direction of pharmacogenomics,and to provide a basis for further scientific research.Methods:Articles were searched from Web of Science and analyzed by bibliometrics.Results:A total of 8037 references of pharmacogenomics were recorded.The total number has increased quickly during the recent years.The top 10 core journals were found such as Pharmacogenomics,and Mcleod HL is the prolific writer.Top 10 papers of pharmacogenomics in terms of cited frequency were also listed.A great progress has achieved in pharmacogenomic research during the past years in China,but is still lagging behind developed countries.Conclusion:The pharmacogenomics has attracted more and more attention.More studies on pharmacogenomics are expected in the future,and the level of investment and research should be improved in China.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第13期1194-1197,1211,共5页 Chinese Journal of New Drugs
基金 国家"重大新药创制"科技重大专项心脑血管疾病新药临床评价技术平台研究(2008ZX09312-005) 卫生行业科研专项基金"药物使用安全与输血安全相关技术与标准"(200902008-03)
关键词 药物基因组学 WEB of SCIENCE 文献计量分析 pharmacogenomics Web of Science bibliometrics
  • 相关文献

参考文献13

  • 1SIEST G, JEANNESSON E, BERRAHMOUNE H, et al. Phar- macogenomics and drug response in cardiovascular disorders[ J]. Pharmacogenomics, 2004, 5 (7) : 779 - 802.
  • 2PRICEEVA DA. Pharmacogenetics [ J ]. Acta Genet Med Gemellol, 1962,11(3) :335.
  • 3ANGST MS, PHILLLIPS NG, DROVER DR, et al. Opioid pharmacogenomics using a twin study paradigm: methods and procedures for determining familial aggregation and heritability [J]. Twin Res Human Genet, 2010,13(5) :412 -425.
  • 4MARSHALL A. Genset-Abbott deal heralds pharmacogenomics era [ J ]. Nat Biotechnol, 1997,15 ( 9 ) : 829 - 830.
  • 5EVANS WE, RELLING MV. Pharmacogenomics: translating functional genomics into rational therapeutics [ J ]. Science, 1999, 286(5439) :487 -491.
  • 6ROSES AD. Pharmacogenetics and the practice of medicine[J]. Nature, 2000,405 ( 6788 ) : 857 - 865.
  • 7SUBRAMANIAN GA, DAMS MD, VENTER JC, et al. Implica- tions of the human genome for understanding human biology and medicine [ J ]. JAMA, 2001,286 ( 18 ) : 2296 - 2307.
  • 8EVANS WE, MCLEOD HL. Pharmacogenomics-drug disposi- tion, drug targets,and side effects[ J]. N Engl J Med,2003,348 (6) :538 -549.
  • 9MCLEOD HL, SARGENT DJ, MARSH S, et al. Pharmacoge- netic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from north american gas-trointestinal intergroup trial N9741 [ J ]. J Clin Oncol, 2010,28 (20) :3227 -3233.
  • 10MCLEOD HL. Using patient DNA to optimize therapy in heart failure patients: a move toward perfeetion [ J ]. Heart Fail Rev, 2010,15(3) :183 - 185.

二级参考文献22

  • 1[1]Collins FS,Green ED,Guttmacher AE,et al.A vision forthe future of genomics research[J]. Nature, 2003,422-847
  • 2[2]Evans WE,Relling MV.Pharmacogenomics:translatingfunctional genomics into rational therapeutics[J].Science, 1999,286:487-491
  • 3[3]Meyer UA.Introduction to pharmacogenomics:promises,opportunities,and limitations[A].In:Licinio J,Wong ML,edited. Pharmacogenomics:the search for individualized therapies[M].Weinheim:Weley VCH Verlag,2002.1-8
  • 4[4]Vesell ES.Advances in pharmacogenetics and pharmacoge-nomics[J].J Clin Pharmacol, 2000,40:930-938
  • 5[5]Bailey DS,Bondar A,Furness LM.Pharmacogenomics-it′s not just pharmacogenetics[J]. Curr Opin Biotechnol, 1998,9:595-601
  • 6[6]Lindpaintner K.The impact of pharmacogenetics and pharmacogenomics on drug discovery[J].Nat Rev Drug Discov, 2002,1:463-469
  • 7[7]Essiox L,Destenaves B,Jais P,et al.Association studies in pharmacogenomics.In:Licinio J,Wong ML,editors.Pharmacogenomics:the search for individualized therapies[M].Weinheim:Weley-VCH Verlag,2002.57-82
  • 8[8]Altman RB,Klein TE.Challenges for biomedical informatics and pharmacogenomics[J].Annu Rey Pharmacol Toxicol, 2002,42:113-133
  • 9[9]Pirmohamed M.Pharmacogenetics and pharmacogenomics[J]. Br J Clin Pharmacol, 2001,52:345-347
  • 10[10]Marshall A.Genset-Abbott deal heralds pharmacogenomics era[J].Nat Biotechnol 1997,15:829-830

共引文献6

同被引文献80

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部